Zura Bio Ltd - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Name: Zura Bio Ltd - Ordinary Shares - Class A: Is Infosys Ltd. worth buying?
Item: Zura Bio Ltd - Ordinary Shares - Class A
Rating: 2.07250
Author: Trendlyne DVM scores

about

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is de...

3.44 0.23 (7.17%)

30.92% Fall from 52W High

573.1K

XNAS Volume

XNAS 20 Oct, 2025 3:18 PM (EDT)

Not Eligible

Expensive Valuation

11.5 / 100

Technically Bullish

71.4 / 100

No estimates available

Zura Bio Ordinary Shares Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Zura Bio Ltd - Ordinary Shares - Class A Live Stock Price Today, Share Analysis and Chart

Zura Bio Ltd is a clinical-stage, multi-asset immunology company developing novel dual-pathway antibodies for autoimmune and inflammatory diseases. It is developing three assets which have completed Phase I/Ib studies and are Phase II ready. It is de...

30.92% Fall from 52W High

SWOT Analysis

Zura Bio Ordinary Shares Live Price Chart